Biosynthetic gene clusters encode the enzymatic pathways to make secondary metabolites, molecules of great interest for the pharmaceutical and biotechnology industries. Access to an increasing number of microbial genomes, coupled with efficient bioinformatic tools, is creating new momentum in secondary metabolite research.
References
Bérdy, J. J. Antibiot. (Tokyo) 58, 1–26 (2005).
Corre, C. & Challis, G.L. Nat. Prod. Rep. 26, 977–986 (2009).
Cimermancic, P. et al. Cell 158, 412–421 (2014).
Weber, T. Int. J. Med. Microbiol. 304, 230–235 (2014).
Ziemert, N. et al. Proc. Natl. Acad. Sci. USA 111, 1130–1139 (2014).
Letzel, A.C. et al. Nat. Prod. Rep. 30, 392–428 (2013).
Rinke, C. et al. Nature 499, 431–437 (2013).
Wilson, M.C. & Piel, J. Chem. Biol. 20, 636–647 (2013).
Umemura, M. et al. PLoS ONE 8, e84028 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Caboche, S. Bioinformatics bolster a renaissance. Nat Chem Biol 10, 798–800 (2014). https://doi.org/10.1038/nchembio.1634
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1634
- Springer Nature America, Inc.